WO1997017945A3 - Methods and compositions for the delivery of monomeric proteins - Google Patents

Methods and compositions for the delivery of monomeric proteins Download PDF

Info

Publication number
WO1997017945A3
WO1997017945A3 PCT/US1996/018115 US9618115W WO9717945A3 WO 1997017945 A3 WO1997017945 A3 WO 1997017945A3 US 9618115 W US9618115 W US 9618115W WO 9717945 A3 WO9717945 A3 WO 9717945A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
delivery
multimeric
methods
exit
Prior art date
Application number
PCT/US1996/018115
Other languages
French (fr)
Other versions
WO1997017945A2 (en
Inventor
Antwerp William P Van
Antwerp Nannette Van
Original Assignee
Minimed Inc
Antwerp William P Van
Antwerp Nannette Van
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minimed Inc, Antwerp William P Van, Antwerp Nannette Van filed Critical Minimed Inc
Priority to AU76781/96A priority Critical patent/AU7678196A/en
Priority to EP96939664A priority patent/EP0861089B1/en
Priority to DK96939664T priority patent/DK0861089T3/en
Priority to CA002236579A priority patent/CA2236579C/en
Priority to JP51899697A priority patent/JP4307550B2/en
Priority to DE69622421T priority patent/DE69622421T2/en
Publication of WO1997017945A2 publication Critical patent/WO1997017945A2/en
Publication of WO1997017945A3 publication Critical patent/WO1997017945A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

Methods and devices for dissociating multimeric proteins and their delivery to patients, along with resultant compositions, are provided. A monomeric protein delivery device is also provided, comprising a supply of a multimeric protein (4) complex, comprising multimeric protein and an aggregating agent; a flow path having a subcutaneous exit (8), fluidly coupling the multimeric protein supply to the exit; a porous surface assembly situated along the flow path comprising a porous surface (10); and an aggregating agent binding partner carried by the surface (12); whereby the aggreagating agent of the multimeric protein complex passing along the surface is bound to the binding partner on the surface to create a monomeric protein flow through the subcutaneous exit.
PCT/US1996/018115 1995-11-13 1996-11-12 Methods and compositions for the delivery of monomeric proteins WO1997017945A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AU76781/96A AU7678196A (en) 1995-11-13 1996-11-12 Methods and compositions for the delivery of monomeric proteins
EP96939664A EP0861089B1 (en) 1995-11-13 1996-11-12 Methods and compositions for the delivery of monomeric proteins
DK96939664T DK0861089T3 (en) 1995-11-13 1996-11-12 Methods and compositions for administration of monomeric proteins
CA002236579A CA2236579C (en) 1995-11-13 1996-11-12 Methods and compositions for the delivery of monomeric proteins
JP51899697A JP4307550B2 (en) 1995-11-13 1996-11-12 Methods and compositions for delivery of monomeric proteins
DE69622421T DE69622421T2 (en) 1995-11-13 1996-11-12 METHOD AND COMPOSITIONS FOR ADMINISTRATING MONOMERIC PROTEINS

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US661195P 1995-11-13 1995-11-13
US60/006,611 1995-11-13

Publications (2)

Publication Number Publication Date
WO1997017945A2 WO1997017945A2 (en) 1997-05-22
WO1997017945A3 true WO1997017945A3 (en) 1997-07-10

Family

ID=21721720

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1996/018115 WO1997017945A2 (en) 1995-11-13 1996-11-12 Methods and compositions for the delivery of monomeric proteins

Country Status (8)

Country Link
US (1) US5807315A (en)
EP (1) EP0861089B1 (en)
JP (1) JP4307550B2 (en)
AU (1) AU7678196A (en)
CA (1) CA2236579C (en)
DE (1) DE69622421T2 (en)
DK (1) DK0861089T3 (en)
WO (1) WO1997017945A2 (en)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6428771B1 (en) * 1995-05-15 2002-08-06 Pharmaceutical Discovery Corporation Method for drug delivery to the pulmonary system
US6042561A (en) * 1997-10-22 2000-03-28 Ash Medical Systems, Inc. Non-intravascular infusion access device
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US6444226B1 (en) * 1999-06-29 2002-09-03 Pharmaceutical Discovery Corporation Purification and stabilization of peptide and protein pharmaceutical agents
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US7041468B2 (en) 2001-04-02 2006-05-09 Therasense, Inc. Blood glucose tracking apparatus and methods
AU2003220125B2 (en) 2002-03-20 2006-06-15 Mannkind Corporation Inhalation apparatus
WO2004061420A2 (en) 2002-12-31 2004-07-22 Therasense, Inc. Continuous glucose monitoring system and methods of use
AU2004232858B2 (en) 2003-04-23 2009-07-09 Mannkind Corporation Hydraulically actuated pump for long duration medicament administration
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US7338171B2 (en) * 2003-10-27 2008-03-04 Jen-Chuen Hsieh Method and apparatus for visual drive control
KR100985126B1 (en) * 2004-01-12 2010-10-05 맨카인드 코포레이션 A method of reducing serum proinsulin levels in type 2 diabetics
EP1718198A4 (en) 2004-02-17 2008-06-04 Therasense Inc Method and system for providing data communication in continuous glucose monitoring and management system
PT2319500E (en) * 2004-03-12 2013-01-23 Biodel Inc Rapid acting drug delivery compositions
US20080085298A1 (en) * 2004-03-12 2008-04-10 Biodel, Inc. Rapid Mucosal Gel or Film Insulin Compositions
US20080096800A1 (en) * 2004-03-12 2008-04-24 Biodel, Inc. Rapid mucosal gel or film insulin compositions
US20080090753A1 (en) * 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
US9089636B2 (en) 2004-07-02 2015-07-28 Valeritas, Inc. Methods and devices for delivering GLP-1 and uses thereof
PL1786784T3 (en) 2004-08-20 2011-04-29 Mannkind Corp Catalysis of diketopiperazine synthesis
EP2322180B1 (en) 2004-08-23 2015-05-27 MannKind Corporation Diketopiperazine salts for drug delivery
DE102005011656A1 (en) * 2005-03-14 2006-09-21 Breeze Medical, Inc., Boca Raton System for delivering an agent into a blood vessel
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
RU2390325C2 (en) 2005-09-14 2010-05-27 Маннкайнд Корпорейшн Method for preparing drug based on higher affinity of active agents to crystalline microparticle surfaces
US8084420B2 (en) * 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
US7713929B2 (en) 2006-04-12 2010-05-11 Biodel Inc. Rapid acting and long acting insulin combination formulations
US20070086952A1 (en) * 2005-09-29 2007-04-19 Biodel, Inc. Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
RU2403059C2 (en) 2006-02-22 2010-11-10 Маннкайнд Корпорейшн Method of improving pharmaceutical properties of particles, containing diketopiperazine and active agent
AU2007233231B2 (en) 2006-03-30 2011-02-24 Mannkind Corporation Multi-cartridge fluid delivery device
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US7718609B2 (en) * 2006-04-12 2010-05-18 Biodel Inc. Rapid acting and long acting insulin combination formulations
WO2007143225A2 (en) 2006-06-07 2007-12-13 Abbott Diabetes Care, Inc. Analyte monitoring system and method
US10154804B2 (en) 2007-01-31 2018-12-18 Medtronic Minimed, Inc. Model predictive method and system for controlling and supervising insulin infusion
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
WO2008124522A2 (en) * 2007-04-04 2008-10-16 Biodel, Inc. Amylin formulations
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
CN101951957A (en) * 2008-01-04 2011-01-19 百达尔公司 Insulin discharges the insulin preparation as the function of the glucose level of tissue
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8636001B2 (en) 2008-06-13 2014-01-28 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
DK2609954T3 (en) 2008-06-20 2022-02-14 Mannkind Corp Interactive device for real-time imaging of inhalation performance
TWI614024B (en) 2008-08-11 2018-02-11 曼凱公司 Use of ultrarapid acting insulin
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
AU2009293019A1 (en) 2008-09-19 2010-03-25 Tandem Diabetes Care Inc. Solute concentration measurement device and related methods
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US9060927B2 (en) * 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
EP2405963B1 (en) 2009-03-11 2013-11-06 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
WO2010127050A1 (en) 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US9184490B2 (en) 2009-05-29 2015-11-10 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
CN102647979B (en) 2009-06-12 2015-03-04 曼金德公司 Diketopiperazine particles with defined specific surface areas
CA2769030C (en) 2009-07-30 2016-05-10 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US9314195B2 (en) 2009-08-31 2016-04-19 Abbott Diabetes Care Inc. Analyte signal processing device and methods
WO2011026148A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
WO2011041469A1 (en) 2009-09-29 2011-04-07 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
EP2582421A1 (en) 2010-06-21 2013-04-24 MannKind Corporation Dry powder drug delivery system and methods
WO2012135765A2 (en) 2011-04-01 2012-10-04 Mannkind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
CN103945859A (en) 2011-10-24 2014-07-23 曼金德公司 Methods and compositions for treating pain
EP2775918B1 (en) 2011-11-07 2020-02-12 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US10130767B2 (en) 2012-08-30 2018-11-20 Medtronic Minimed, Inc. Sensor model supervisor for a closed-loop insulin infusion system
US9878096B2 (en) 2012-08-30 2018-01-30 Medtronic Minimed, Inc. Generation of target glucose values for a closed-loop operating mode of an insulin infusion system
KR102054540B1 (en) 2012-08-30 2019-12-10 메드트로닉 미니메드 인코포레이티드 Safeguarding techniques for a closed-loop insulin infusion system
US10496797B2 (en) 2012-08-30 2019-12-03 Medtronic Minimed, Inc. Blood glucose validation for a closed-loop operating mode of an insulin infusion system
US9662445B2 (en) 2012-08-30 2017-05-30 Medtronic Minimed, Inc. Regulating entry into a closed-loop operating mode of an insulin infusion system
US9849239B2 (en) 2012-08-30 2017-12-26 Medtronic Minimed, Inc. Generation and application of an insulin limit for a closed-loop operating mode of an insulin infusion system
US9623179B2 (en) 2012-08-30 2017-04-18 Medtronic Minimed, Inc. Safeguarding techniques for a closed-loop insulin infusion system
US9364609B2 (en) 2012-08-30 2016-06-14 Medtronic Minimed, Inc. Insulin on board compensation for a closed-loop insulin infusion system
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
AU2013346624B2 (en) 2012-11-13 2018-08-09 Adocia Quick-acting insulin formulation including a substituted anionic compound
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
SG11201507564PA (en) 2013-03-15 2015-10-29 Mannkind Corp Microcrystalline diketopiperazine compositions and methods
MX2020009878A (en) 2013-07-18 2022-07-27 Mannkind Corp Heat-stable dry powder pharmaceutical compositions and methods.
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
GB201607918D0 (en) 2016-05-06 2016-06-22 Arecor Ltd Novel formulations

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2114573A (en) * 1982-02-05 1983-08-24 Novo Industri As Stabilized insulin solutions and methods for their production

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US507885A (en) * 1893-10-31 Apparatus for purifying asphalt
US4183849A (en) * 1975-01-15 1980-01-15 Nordisk Insulinlaboratorium Therapeutic insulin preparation and a process for the production of a stable insulin preparation with protracted effect
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
US4861705A (en) * 1983-01-31 1989-08-29 Yeda Research And Development Company, Ltd. Method for removing components of biological fluids
US4940456A (en) * 1987-02-10 1990-07-10 Dan Sibalis Electrolytic transdermal delivery of proteins
US4931498A (en) * 1988-02-25 1990-06-05 Purdue Research Foundation Immobilized artificial membranes
US5597485A (en) * 1988-05-13 1997-01-28 Vilmax S.A. Process for separating proteins
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
DK10191D0 (en) * 1991-01-22 1991-01-22 Novo Nordisk As HIS UNKNOWN PEPTIDES
US5505713A (en) * 1994-04-01 1996-04-09 Minimed Inc. Indwelling catheter with stable enzyme coating
JP3148591B2 (en) * 1994-09-13 2001-03-19 トヨタ自動車株式会社 Method and apparatus for separating / removing metal contained in solution

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2114573A (en) * 1982-02-05 1983-08-24 Novo Industri As Stabilized insulin solutions and methods for their production

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MICHAEL J. TIERNEY ET AL.: "Electroreleasing Composite Membranes for Delivery of Insulin and Other Biomacromolecules", JOURNAL OF THE ELECTROCHEMICAL SOCIETY, vol. 137, no. 6, June 1990 (1990-06-01), US, pages 2005 - 2006, XP002031036 *

Also Published As

Publication number Publication date
EP0861089A2 (en) 1998-09-02
DE69622421D1 (en) 2002-08-22
JP2000502993A (en) 2000-03-14
CA2236579A1 (en) 1997-05-22
US5807315A (en) 1998-09-15
DK0861089T3 (en) 2002-10-07
DE69622421T2 (en) 2003-03-20
CA2236579C (en) 2009-06-30
WO1997017945A2 (en) 1997-05-22
EP0861089B1 (en) 2002-07-17
AU7678196A (en) 1997-06-05
JP4307550B2 (en) 2009-08-05

Similar Documents

Publication Publication Date Title
WO1997017945A3 (en) Methods and compositions for the delivery of monomeric proteins
GB9715660D0 (en) Proteins
BG104149A (en) Interleukin-18-binding proteins, methods for their preparation and administration
AU7087891A (en) Modified hil-6
IL132380A0 (en) Compositions comprising conjugates of stable active human ob protein with antibody fc chain and methods
WO1996007652B1 (en) Calicheamicin mimics
DK1394179T3 (en) Process for the preparation of erythropoietin free of animal proteins
WO1991018047A3 (en) Mammalian expression of the bmp-2 family
DE69114649T2 (en) In-line gas / liquid dispersion.
DE69534778D1 (en) Cathepsin-02-protease
TR199701544T1 (en) New dolastatin derivatives, their preparation and use.
CA2182289A1 (en) Immuno-stimulatory monoclonal antibodies
ES8505828A1 (en) A filter for purifying drinkable and non-drinkable water.
NZ304570A (en) Neurone-restrictive silencer factor proteins, nucleic acids and antibodies thereto
EP1980573A3 (en) Isolated dendritic cell membrane protein genes
WO1996007738A3 (en) Modified human c3 proteins
WO2001025438A3 (en) Ifn-alpha homologues
MX9603915A (en) Reference electrode assembly.
EP1083332A3 (en) Metering equipment
WO1992011367A3 (en) Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof
EP0994121A3 (en) Branched peptides in assays for antibodies
ATE348107T1 (en) CHLAMYIDIA TRACHOMATIS SPECIFIC PEPTIDES AND THEIR USE IN DETECTION METHOD
EP0819690A3 (en) Herbicidal 6-thienyl and 4-thienyl pyrimidines
WO2003025120A3 (en) Clasp membrane proteins
IT1277558B1 (en) COMBINED VALVE FOR HYDRAULIC PUMPS CHOKED ON THE INTAKE

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2236579

Country of ref document: CA

Ref country code: CA

Ref document number: 2236579

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1997 518996

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1996939664

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1996939664

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 1996939664

Country of ref document: EP